This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials New data show ...
Tinea capitis causes hair loss, scaling, erythema, and impetigo-like lesions. It is the most common dermatophyte infection found in children under the age of 12, especially in African Americans. A ...
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12 “While patients may start to develop symptoms of alopecia areata at any age, most people start ...
Fungus can do a lot for us — make bread, make beer and cure infections, in the case of penicillin. But when the fungus infects us, well, that’s not nearly as much fun as beer. From your head to your ...
Deucravacitinib was safe and effective for treating moderate to severe scalp psoriasis over 16 weeks, even among patients with less extensive overall disease. Deucravacitinib demonstrates significant ...
Hosted on MSN
The Top Antifungal Creams and How to Choose
Antifungal creams like clotrimazole (Canesten), econazole, miconazole, and terbinafine (Lamisil) are commonly used to treat fungal skin and nail infections. The right one for you depends on the type ...
Baricitinib (Olumiant; Eli Lilly), an oral Janus kinase (JAK) 1/2 inhibitor, led to significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks in adolescents with severe alopecia areata, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results